CorMedix (CRMD) Earnings Analysis
CorMedix (CRMD) next reports earnings on 2026-08-06, consensus EPS 0.26 USD. Last quarter (2026-05-14) it beat with EPS 0.43 USD vs 0.35 USD est (+22.9%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E 3.34.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CRMD next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.26 USD |
| Revenue estimate | 0.10B |
CRMD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | 0.43 USD | 0.35 USD | +22.9% | Beat |
| 2026-03-05 | 0.61 USD | 0.86 USD | -29.1% | Miss |
| 2024-10-30 | -0.05 USD | -0.1 USD | +50% | Beat |
| 2024-08-14 | -0.25 USD | -0.26 USD | +3.8% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
CRMD valuation and analyst view
| Trailing P/E | 3.34 |
|---|---|
| Trailing EPS | 2.277 USD |
| Price / book | 1.44 |
| Dividend yield | 0.00% |
| Market cap | 0.62B |
| Analyst consensus | Buy (8 buy / 0 hold / 0 sell) |
| Avg price target | 14 USD |
Related research pages
Frequently asked questions
When is CorMedix (CRMD)'s next earnings date?
CorMedix is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.26 USD and revenue estimate of 0.10B.
Did CRMD beat earnings last quarter?
In its 2026-05-14 report, CRMD posted EPS of 0.43 USD versus a 0.35 USD estimate — a beat of 22.9%.
What is CRMD's earnings track record?
Over the last 4 reported quarters with consensus data, CRMD beat estimates 3 times (75%).
What is CRMD's current P/E ratio and EPS?
CRMD trades at a trailing P/E of 3.34 on trailing EPS of 2.276624055138412 USD.
What do analysts rate CRMD?
Analyst consensus is "Buy" across 8 ratings (0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 14 USD.